Highlights and Quick Summary
- Issuance/Purchase of Shares for the quarter ending September 30, 2023 was $318 Thousand (a 324.0% increase compared to previous quarter)
- Year-over-year quarterly Issuance/Purchase of Shares decreased by -99.83%
- Annual Issuance/Purchase of Shares for 2022 was $186 Million (a -31.38% decrease from previous year)
- Annual Issuance/Purchase of Shares for 2021 was $270 Million (a 673.49% increase from previous year)
- Twelve month Issuance/Purchase of Shares ending September 30, 2023 was $186 Million (a 0.14% increase compared to previous quarter)
- Twelve month trailing Issuance/Purchase of Shares decreased by -59.22% year-over-year
Trailing Issuance/Purchase of Shares for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| $186 Million | $186 Million | $186 Million | $456 Million |
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Issuance/Purchase of Shares of Prime Medicine, Inc.
Most recent Issuance/Purchase of Sharesof PRME including historical data for past 10 years.Interactive Chart of Issuance/Purchase of Shares of Prime Medicine, Inc.
Prime Medicine, Inc. Issuance/Purchase of Shares for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.32 | $0.08 | $0.07 | – | – |
| 2022 | – | – | $185.47 | $0.06 | $185.54 |
| 2021 | – | – | $0.0 | $270.36 | $270.36 |
| 2020 | $34.95 | – | – | – | $34.95 |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology